Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 13, 2019
[A Case of Small Cell Lung Cancer Diagnosed with Metastasis-Induced Acute Pancreatitis]Noriaki Ito, Hideto Oshita, Shoko Isoyama, et al.
Respiratory Investigation|April 14, 2021
Efficacy of mepolizumab in elderly patients with severe asthma and overlapping COPD in real-world settings: A retrospective observational studyShoko Isoyama, Nobuhisa Ishikawa, Kosuke Hamai, et al.
Thoracic Cancer|April 16, 2020
First-line immune checkpoint therapy in metastatic squamous cell lung cancer harboring both EGFR mutation and high expression of PD-L1: A case reportKosuke Hamai, Hiroki Tanahashi, Sayaka Ueno, et al.
Internal Medicine (Tokyo, Japan)|June 1, 2022
Switching Treatment from Mepolizumab to Benralizumab for Elderly Patients with Severe Eosinophilic Asthma: A Retrospective Observational StudyShoko Isoyama, Nobuhisa Ishikawa, Kosuke Hamai, et al.
Thoracic Cancer|March 30, 2026
Tumor-Bearing Status Accelerates Bleomycin-Induced Pulmonary Inflammation via Endothelial ActivationShoko Isoyama, Kakuhiro Yamaguchi, Hiroshi Iwamoto, et al.
International Journal of Clinical Oncology|September 3, 2022
Predictive role of circulatory levels of high-mobility group box 1 for radiation pneumonitis in patients with non-small cell lung cancer treated with definitive thoracic radiotherapyShoko Isoyama, Kakuhiro Yamaguchi, Nobuki Imano, et al.
Respiratory Investigation|March 21, 2022
Effect of baricitinib in patients with coronavirus disease 2019 and respiratory failure: A propensity score-matched retrospective cohort studyTakuya Tanimoto, Shinpei Tada, Suguru Fujita, et al.
Thoracic Cancer|April 30, 2022
Phase 2 study of first-line pembrolizumab monotherapy in elderly patients with non-small-cell lung cancer expressing high PD-L1Takeshi Masuda, Kazunori Fujitaka, Tomoko Suzuki, et al.
Pageof 1